# Discontinuation Versus Continuation of Riociguat Monotherapy in Chronic Thromboembolic Pulmonary Hypertension Successfully Treated With Balloon Pulmonary Angioplasty

> **NCT07644377** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 150 (estimated)

## Conditions studied

- CTEPH

## Interventions

- **DRUG:** Discontinuation of riociguat

## Key facts

- **NCT ID:** NCT07644377
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-11-01
- **Primary completion:** 2031-01-31
- **Final completion:** 2031-01-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07644377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07644377, "Discontinuation Versus Continuation of Riociguat Monotherapy in Chronic Thromboembolic Pulmonary Hypertension Successfully Treated With Balloon Pulmonary Angioplasty". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07644377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*